I am looking forward to delving into the specific implications of the laws in the area of clinical trials, and how to successfully achieve and maintain compliance
SANTA BARBARA, Calif. (PRWEB) July 10, 2018
USDM Life Sciences, the leading risk management, technological innovation and business process optimization firm for life sciences announces a live online workshop on GDPR and Clinical Trials presented by Diane Gleinser, Vice President of Life Science Services and Solutions and Erin Northington, Vice President of Emerging Life Sciences and Clinical at USDM.
- What: Live Workshop – Changes to the GDPR and Clinical Trials – What do You Need to Know?
- When: Thursday, July 19 at 11am PT / 2pm ET / 6pm GMT
- Who: Diane Gleinser, Vice President of Life Science Services and Solutions and Erin Northington, Vice President of Emerging Life Sciences and Clinical at USDM Life Sciences
- Where: Register Here
The Data Protection Directive originally implemented in the EU in 1995 was recently replaced by the General Data Protection Regulation (GDPR). How does this affect your clinical trials? What do you need to know? Join USDM’s subject matter experts for this informative webinar.
“The GDPR implemented in May of this year has major ramifications for businesses of all types,” remarked Diane Gleinser, Vice President of Life Sciences Services and Solutions. “I am looking forward to delving into the specific implications of the laws in the area of clinical trials, and how to successfully achieve and maintain compliance.”
The discussion will include:
- What is GDPR?
- Explanation of increased scope on regulations
- Data subject rights
- How to design privacy into clinical studies
- Live Q & A session
Diane Gleinser is the Senior Vice President of Life Science Services and Solutions at USDM Life Sciences. Diane has more than 27 years of experience in life science-based industries, encompassing quality assurance, quality control, validation and regulatory compliance for research and development, clinical affairs, manufacturing and packaging, laboratory setup and analysis, and auditing under cGMP, cGLP and cGCP regulations and 21 CFR Part 11.
Erin Northington is Vice President of Emerging Life Sciences and Clinical at USDM Life Sciences. Erin has two decades of experience in Clinical Applications, Business Relationship Management and Project Management. She also has a background in GCP compliance, vendor evaluation and management, systems validation and implementations, as well as process evaluation and improvement. She specializes in managing global enterprise-wide IT implementations of technology solutions.
About USDM Life Sciences:
USDM Life Sciences is a global life science and healthcare services company, providing strategy and compliant technology solutions to regulated industries. If you work in Life Sciences or Healthcare, partnering with USDM Life Sciences makes it easy to accelerate innovation and maximize productivity. USDM Life Sciences only focuses on regulated industries and has built trusted partnerships with the most innovative technology companies in the world, and boast a staff of industry leading experts in the areas of technology and compliance. USDM Life Sciences is doing business as USDM Europe GmbH in Germany.